Andersson M, Alvarez-Cermeno J, Bernardi G et al (1994) Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatry 57:897–902
PubMedPubMedCentralCrossRefBechter K, Reiber H, Herzog S, Fuchs D, Tumani H, Maxeiner HG (2010) Cerebrospinal fluid analysis in affective and schizophrenic spectrum disorders. Identification of subgroups with immune responses and blood-CSF barrier dysfunction. J Psychiatr Res 44:321–330
PubMedCrossRefBridel C, Courvoisier DS, Vuilleumier N, Lalive PH (2015) Cerebrospinal fluid angiotensin-converting enzyme for diagnosis of neurosarcoidosis. J Neuroimmunol 285:1–3
PubMedCrossRefBurkhardt D, Schipper HI, Kaboth U, Felgenhauer K (1992) IgA producing primary intracerebral lymphoma. J Neurol Neurosurg Psychiatry 55:623–625
PubMedPubMedCentralCrossRefCarpio A, Campoverde A, Romo ML, García L, Piedra LM, Pacurucu M, López N, Aguilar J, López S, Vintimilla LC, Toral AM, Peña-Tapia P (2017) Validity of a PCR assay in CSF for the diagnosis of neurocysticercosis. Neurol Neuroimmunol Neuroinflamm 4(2):e324
PubMedPubMedCentralCrossRefCinque P, Cleator GM, Weber T, Monteyne P, Sindic CJ, Van Coon AM (1996) The role of laboratory investigation in the diagnosis and management of patients with suspected herpes simplex encephalitis: a consensus report. J Neurol Neurosurg Psychiatry 61:339–345
PubMedPubMedCentralCrossRefCinque P, Scarpellini P, Vago L et al (1997) Diagnosis of central nervous system complications in HIV-infected patients: cerebrospinal fluid analysis by the polymerase chain reaction. AIDS 11:1–17
PubMedCrossRefConrad AJ, Chiang EY, Andeen LE et al (1994) Quantitation of intrathecal measles virus IgG antibody synthesis rate: subacute sclerosing panencephalitis and multiple sclerosis. J Neuroimmunol 54:99–108
PubMedCrossRefDorta AJ, Reiber H (1998) Intrathecal synthesis of immunoglobulins in eosinophilic meningoencephalitis due to Angiostrongylus cantonensis. Clin Diagn Lab Immunol 5:452–455
Ebinger M, Grauer MT, Uhr M (2005) Intrathecal IgA synthesis in neurosyphilis. J Neurol Sci 228:21–25
PubMedCrossRefFelgenhauer K (1988) Prozesslokalisation, Krankheitsphase und Liquorzusammensetzung. In: Holzgraefe M, Reiber H, Felgenhauer K (Hrsg) Labordiagnostik von Erkrankungen des Nervensystems. Perimed, Erlangen, S 84–92
Felgenhauer K, Reiber H (1992) The diagnostic relevance of antibody specificity indices in multiple sclerosis and herpes virus induced diseases of the nervous system. Clin Investig 70:28–37
PubMedCrossRefGraef I, Henze T, Reiber H (1994) Polyspezifische Immunreaktion im ZNS bei Autoimmunerkrankungen mit ZNS Beteiligung. Z Arztl Fortbild 88:587–691
Harrer A, Tumani H, Niendorf S, Lauda F, Geis C, Weishaupt A, Kleinschnitz C, Rauer S, Kuhle J, Stangel M, Weber F, Uhr M, Linnebank M, Wildemann B, Jarius S, Guger M, Ayzenberg I, Chan A, Zettl U, Wiendl H, Pilz G, Hitzl W, Weber JR, Kraus J (2013) Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy. Mult Scler 19(9):1209–1212
PubMedCrossRefJacobi C, Reiber H (1988) Clinical relevance of increased neuron-specific enolase concentration in cerebrospinal fluid. Clin Chim Acta 177:49–54
PubMedCrossRefJacobi C, Lange P, Reiber H (2007) Quantitation of intrathecal antibodies in cerebrospinal fluid of subacute sclerosing panencephalitis, herpes simplex encephalitis and multiple sclerosis: discrimination between microorganism-driven and polyspecific immune response. J Neuroimmunol 187:139–146
PubMedCrossRefJesse S, Steinacker P, Lehnert S, Gillardon F, Hengerer B, Otto M (2009) Neurochemical approaches in the laboratory diagnosis of Parkinson’s and Parkinson’s dementia syndromes: a review. CNS Neurosci Ther 15(2):157–182
PubMedPubMedCentralCrossRefKluge H, Wieczorek V, Linke E, Zimmermann K, Witte OW (2005) Atlas der praktischen Liquorzytologie. Thieme, Stuttgart
CrossRefKorenke GC, Reiber H, Hunnemann DH, Hanefeld F (1997) Intrathecal IgA synthesis in X-linked cerebral adrenoleukodystrophy. J Child Neurol 12(5):314–320
PubMedCrossRefKuehne LK, Reiber H, Bechter K, Hagberg L, Fuchs D (2013) Cerebrospinal fluid neopterin is brain-derived and not associated with blood-CSF barrier dysfunction in non-inflammatory affective and schizophrenic spectrum disorders. J Psychiatr Res 47(10):1417–1422
Kuhle J, Barro C, Disanto G, Mathias A, Soneson C, Bonnier G, Yaldizli Ö, Regeniter A, Derfuss T, Canales M, Schluep M, Du Pasquier R, Krueger G, Granziera C (2016) Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity. Mult Scler 22(12):1550–1559
PubMedCrossRefLejon V, Reiber H, Legros D et al (2003) Intrathecal immune response pattern for improved diagnosis of central nervous system involvement in trypanosomiasis. J Infect Dis 187:1475–1483
PubMedCrossRefLewerenz J, Jarius S, Wildemann B, Wandinger KP, Leypoldt F (2016) Autoantibody-associated autoimmune encephalitis and cerebellitis: clinical presentation, diagnostic work-up and treatment. Nervenarzt 87(12):1293–1299
PubMedCrossRefLlorens F, Schmitz M, Ferrer I, Zerr I (2016) CSF biomarkers in neurodegenerative and vascular dementias. Prog Neurobiol 138–140:36–53
PubMedCrossRefMcDonald WI, Compston A, Edan G et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121–127
PubMedCrossRefMonteyne PH, Sindic CJM (1995) The diagnosis of tuberculous meningitis. Acta Neurol Belg 95:80–87
PubMedOeckl P, Jardel C, Salachas F et al (2016) Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS. Amyotroph Lateral Scler Frontotemporal Degener 17(5-6):404–413
PubMedCrossRefOtto M, Wiltfang J (2003) Differential diagnosis of neurodegenerative diseases with special emphasis on Creutzfeldt-Jakob disease. Restor Neurol Neurosci 21:191–209
PubMedOtto M, Wiltfang J, Cepek L et al (2002) Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 58:192–197
PubMedCrossRefPasserini G, Dalla Costa G, Sangalli F, Moiola L, Colombo B, Locatelli M, Comi G, Furlan R, Martinelli V (2016) Free light chains and intrathecal B cells activity in multiple sclerosis: a prospective study and meta-analysis. Mult Scler Int 2016:2303857 (online)
Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O’Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS (2010) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69(2):292–302
CrossRefPrange HW, Aue G, Frauendorf H, Reiber H (1995) Die neuronenspezifische Enolase als Prognosemarker bei zerebraler Hypoxie. Intensivmed 32:17–22
Presslauer S, Milosavljevic D, Huebl W, Aboulenein-Djamshidian F, Krugluger W, Deisenhammer F, Senel M, Tumani H, Hegen H (2016) Validation of kappa free light chains as a diagnostic biomarker in multiple sclerosis and clinically isolated syndrome: a multicenter study. Mult Scler 22(4):502–510
PubMedCrossRefQuentin CD, Reiber H (2004) Fuchs’ heterochromic cyclitis: rubella virus antibodies and genome in aqueous humor. Am J Ophthalmol 138(1):46–54
PubMedCrossRefReiber H (1994) Flow rate of cerebrospinal fluid (CSF) – a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases. J Neurol Sci 122(2):189–203
PubMedCrossRefReiber H (2001) Dynamics of brain-derived proteins in cerebrospinal fluid. Clin Chim Acta 310:173–186
PubMedCrossRefReiber H (2003) Proteins in cerebrospinal fluid and blood: barriers, CSF flow rate and source-related dynamics. Restor Neurol Neurosci 21:79–96
PubMedReiber H (2008) Neurologische Untersuchungen/Liquoranalytik. In: Sinha P (Hrsg) Laborbefunde und ihre klinischen Interpretationen, Methoden der Laboruntersuchung, Diagnosestrategien, Differentialdiagnose. Spitta, Balingen
Reiber H (2016a) Knowledge-base for interpretation of Cerebrospinal fluid data patterns – essentials in neurology and psychiatry. Arq Neuropsiquiatr 74(6):501–512
PubMedCrossRefReiber H (2016b) Cerebrospinal fluid data compilation and knowledge-based interpretation of bacterial, viral, parasitic, oncological, chronic inflammatory and demyelinating diseases: diagnostic patterns not to be missed in neurology and psychiatry. Arq Neuropsiquiatr 74(4):337–350
PubMedCrossRefReiber H (2017a) Physiological and biophysical data of proteins in CSF: facts and interpretations by the molecular flux/CSF flow theory for barrier functions (im Druck)
Reiber H (2017b) Chronic diseases with delayed onset after infections and vaccinations: Gulf war illness, autoimmune diseases, post lyme syndrome and chronic fatigue. J Arch Mil Med (review submitted)
Reiber H, Albaum W (2008) Statistical evaluation of intrathecal protein synthesis in CSF/Serum quotient diagrams. Acta Neuropsychiatrica 20(supplement 1):48–49, Free software at
www.albaum.itReiber H, Davey B (1996) Desert-storm-syndrome and immunization. Arch Intern Med 156:217
PubMedCrossRefReiber H, Felgenhauer K (1987) Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system. Clin Chim Acta 163:319–328
PubMedCrossRefReiber H, Peter JB (2001) Cerebrospinal fluid analysis – disease-related data patterns and evaluation programs. J Neurol Sci 184:101–122
PubMedCrossRefReiber H, Ungefehr St, Jacobi C (1998) The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis. Mult Scler 4:111–117
PubMedCrossRefReiber H, Otto M, Trendelenburg C, Wormek A (2001) Reporting cerebrospinal fluid data – knowledge base and interpretation software. Clin Chem Lab Med 39:324–332
Reiber H, Walther K, Althaus H (2003) Beta-trace protein as sensitive marker for CSF Rhinorhea and CSF Otorhea. Acta Neurol Scand 108:1–4
CrossRefReiber H, Teut M, Pohl D, Rostasy KM, Hanefeld F (2009) Paediatric and adult multiple sclerosis: age-related differences and time course of the neuroimmunological response in cerebrospinal fluid. Mult Scler 15:1466–1480
PubMedCrossRefReiber H, Ressel Chr, Spreer A (2013) Diagnosis of neuroborreliosis-improved knowledge base for qualified antibody analysis and cerebrospinal fluid data pattern related interpretations. Neurol Psychiatry Brain Res 19:159–169
CrossRefReiber H, Lange P, Zerr I (2014) Neurochemical dementia diagnostics – interlaboratory variation of analysis, reference ranges and interpretations. J Alzheimers Dis Parkinsonism 4:147–151
Reiber H, Kruse-Sauter H, Quentin CD (2015) Different B cell repertoires in brain and eye of the individual multiple sclerosis patient. Patterns of antibodies, oligoclonal IgG and isotypes in cerebrospinal fluid and aqueous humor. J Neuroimmunol 278:247–254
PubMedCrossRefRobinson-Agramonte M, Reiber H, Cabrera-Gomez JA, Galvizu R (2007) Intrathecal polyspecific immune response to neurotropic viruses in multiple sclerosis: a comparative report from Cuban patients. Acta Neurol Scand 115:312–318
PubMedCrossRefSchaarschmidt H, Prange H, Reiber H (1994) Neuron-specific enolase concentrations in blood as a prognostic parameter in cerebrovascular diseases. Stroke 24:558–565
CrossRefSchmutzhard E (2005) Mikrobiologische Diagnostik im Liquor bei Parasitosen. In: Zettl UK, Lehmitz R, Mix E (Hrsg) Klinische Liquordiagnostik, 2. Aufl. De Gruyter, Berlin
Shoji H, Honda Y, Murai I, Sato Y, Oizumik K, Hondo R (1992) Detection of VZV-DNA by polymerase chain reaction in CSF of patients with herpes zoster meningitis. J Neurol 239:69–70
PubMedCrossRefSindic CJM, Monteyne PH, Laterre EC (1994) The intrathecal synthesis of virus-specific oligoclonal IgG in multiple sclerosis. J Neuroimmunol 54:75–80
PubMedCrossRefStauch C, Reiber H, Rauchenzauner M, Pohl D, Hanefeld F, Gärtner J, Rostásy KM (2011) Intrathecal IgM synthesis in pediatric MS is not a negative prognostic marker of disease progression: quantitative versus qualitative IgM analysis. Mult Scler 17:327–334
PubMedCrossRefTerryberry JW, Shoenfeld Y, Gilburd B et al (1995) Myelin- and microbe-specific antibodies in Guillain-Barré Syndrome. J Clin Lab Anal 9(5):308–319
PubMedCrossRefThompson EJ (2005) The CSF proteins: a biochemical approach, 2. Aufl. Elsevier, Amsterdam
Tumani H, Petzold A, Wick M, Kühn HJ, Uhr M, Otto M, Regeniter A, Brettschneider J (2010) Cerebrospinal fluid-based diagnostics of CT-negative subarachnoid haemorrhage. Nervenarzt 81(8):973–979
PubMedCrossRefUhr M (2001) Neurologische Tropenkrankheiten. In: Prange H, Bitsch A (Hrsg) Infektionserkrankungen des Zentralnervensystems. Wissenschaftliche Verlagsgesellschaft, Stuttgart
Uhr M (2010) Psychiatrische Erkrankungen. In: Wildemann B, Oschmann P, Reiber H (Hrsg) Laboratory diagnosis in neurology. Thieme Verlag, Stuttgart
Uhr M, Tumani H, Lange P (2016) Strategien der Liquorbefundung – integrierter Befundbericht. Nervenarzt 87(12):1271–1275
PubMedCrossRefVaughan K, Peters B, O’Connor KC, Martin R, Sette A (2014) A molecular view of multiple sclerosis and experimental autoimmune encephalitis: what can we learn from the epitope data? J Neuroimmunol 267:73–85
PubMedCrossRefVoltz R (2002) Paraneoplastic neurological syndroms: an update on diagnosis, pathogenesis and therapy. Lancet Neurol 1:294–304
PubMedCrossRefWeber T, Jürgens S, Lüer W (1987) Cerebrospinal fluid immunoglobulins and virus-specific antibodies in disorders affecting the facial nerve. J Neurol 234:308–314
PubMedCrossRefWick M, Gross CC, Isenmann S, Strik H (2016) Cytology of cerebrospinal fluid: standards, importance and modern methods. Nervenarzt 87(12):1271–1275
CrossRefWildemann B, Oschmann P, Reiber H (Hrsg) (2010) Laboratory diagnosis in neurology. Thieme Verlag, Stuttgart
Wiltfang J, Lewczuk P, Otto M (2016) Biomarkers for dementia and other neurodegenerative diseases: current developments. Nervenarzt 87(12):1305–1309
PubMedCrossRefWurster U (2010) Antineuronale Antikörper. In: Wildemann B, Oschmann P, Reiber H (Hrsg) Neurologische Labordiagnostik. Thieme, Stuttgart
Zettl UK, Lehmitz R, Mix E (Hrsg) (2005) Klinische Liquordiagnostik, 2. Aufl. Berlin, De Gruyter